日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preventing surgery-induced natural killer cell suppression and metastases by inhibiting PI3K-gamma signaling in myeloid-derived suppressor cells.

通过抑制髓系来源抑制细胞中的 PI3K-γ 信号传导,防止手术引起的自然杀伤细胞抑制和转移。

Angka Leonard, Tennakoon Gayashan, Cook David P, Martel Andre B, Market Marisa, Tanese de Souza Christiano, Cummins Emma, Samudio Ismael, Kekre Natasha, Ardolino Michele, Vanderhyden Barbara C, Kennedy Michael A, Auer Rebecca C

Doxorubicin enhances adipogenesis in an FGF2-dependent manner and induces a tumour-promoting secretory phenotype.

阿霉素以 FGF2 依赖的方式增强脂肪生成,并诱导促肿瘤分泌表型。

Kreps Lauren M, Yakubovich Edward, Zhao Huijun, Yimer Selam, Yang Edward, Cruz Juliet, Vanderhyden Barbara, Addison Christina L

MRI of combination immunotherapy in an epithelial ovarian cancer preclinical model

在卵巢上皮癌临床前模型中应用MRI评估联合免疫疗法

Gosse, Jessica T; Skelton, Caitrin Sobey; Tremblay, Marie-Laurence; Wyatt, Hailey; Gonzalez, Victoria; Dawod, Bassel; Nuschke, Andrea; Davis, Christa; Dirk, Brennan; Vila-Leahey, Ava; Mackay, Alecia; Bobbitt, Kim; West, Andrea; Vanderhyden, Barbara; Weir, Genevieve; Merkx-Jacques, Alexandra; Stanford, Marianne; Hrytsenko, Olga; Brewer, Kimberly D

Loss of LATS1 and LATS2 promotes ovarian tumor formation by enhancing AKT activity and PD-L1 expression.

LATS1 和 LATS2 的缺失通过增强 AKT 活性和 PD-L1 表达促进卵巢肿瘤的形成

Zhu Yalun, Abedini Atefeh, Rodriguez Galaxia M, McCloskey Curtis W, Abou-Hamad John, Salah Omar Salah, Larocque Janie, Tsoi Mayra F, Boerboom Derek, Cook David, Vanderhyden Barbara

Transglutaminase 2 regulates ovarian cancer metastasis by modulating the immune microenvironment.

转谷氨酰胺酶 2 通过调节免疫微环境来调控卵巢癌转移

Ibrahim Dalia, Grondin Melanie, Galpin Kristianne, Asif Sara, Thompson Emily, Nersesian Sarah, Abou-Hamad John, Echaibi Maryam, Rodriguez Galaxia M, Navals Pauline, Macdonald Elizabeth, Ryan Brianna, Cook David P, Keillor Jeffrey W, Vanderhyden Barbara C

Specific Genetic Mutations Impact Chemotherapy Resistance and Therapeutic Efficacy of Oncolytic Viruses in Ovarian Cancer

特定基因突变影响卵巢癌中溶瘤病毒的化疗耐药性和治疗效果

Cudmore, Alison O; Rodriguez, Galaxia M; Maranda, Vincent; Farokhi Boroujeni, Salar; Murshed, Humaira; Macdonald, Elizabeth A; Grondin, Melanie; Garson, Kenneth; Matuszewska, Kathy; Diallo, Jean-Simon; Petrik, James J; Vanderhyden, Barbara C

P53 Mutation Induces Epithelial-to-Mesenchymal Transition (EMT) Associated with Stem Cell Properties and Tumorigenesis in Fallopian Tube Cells

P53突变诱导输卵管细胞发生上皮间质转化(EMT),该转化与干细胞特性和肿瘤发生相关。

Alwosaibai, Kholoud; Vanderhyden, Barbara C; Alsaffar, Fatimah A; Alamri, Salma; Almotlak, Abdulaziz A

Cancer genetics and response to oncolytic virus treatment for ovarian cancer

卵巢癌的癌症遗传学及对溶瘤病毒治疗的反应

Fletcher, Erin L; Cudmore, Alison O; Vanderhyden, Barbara C

Transcriptional regulation of the postnatal cardiac conduction system heterogeneity

出生后心脏传导系统异质性的转录调控

Yena Oh ,Rimshah Abid ,Saif Dababneh ,Marwan Bakr ,Termeh Aslani ,David P Cook ,Barbara C Vanderhyden ,Jin G Park ,Nikhil V Munshi ,Chi-Chung Hui ,Kyoung-Han Kim

PTEN Loss Shapes Macrophage Dynamics in High-Grade Serous Ovarian Carcinoma

PTEN缺失影响高级别浆液性卵巢癌中巨噬细胞的动态变化

Sarah Spear ,Olivia Le Saux ,Hasan B Mirza ,Nayana Iyer ,Katie Tyson ,Fabio Grundland Freile ,Josephine B Walton ,Chloé Woodman ,Sheba Jarvis ,Darren P Ennis ,Carmen Aguirre Hernandez ,Yuewei Xu ,Pavlina Spiliopoulou ,James D Brenton ,Ana P Costa-Pereira ,David P Cook ,Barbara C Vanderhyden ,Hector C Keun ,Evangelos Triantafyllou ,James N Arnold ,Iain A McNeish